I see your point. The question is will investors see the 7/10 as a good number?Looks to me that the drug is working but that they may need to increase dosage or frequency. Not sure how it will be received if that is the case.
I couldn't agree more. I almost want them to dilute so I can pick up more shares from the nimrods who panic.
This stock has a great chance at returning some huge coin!
Are you serious? I've seen hundreds of these things against biotech and leeches like you who think they deserve money will get NOTHING. You bought a biotech stock so how stupid are you not to expect volatility?
I think the ACAD will keep climbing. My guess is that without news, we will be in the low 50's by weeks end but ultimately I think the stock gets taken out at 58.
I think it's too dangerous to be out of this stock on a trade but good luck if you do.
I've said 50 by year's end and I stand by it. Not on hype but by the hunger for a great HEP C therapy.